Correlation Between TransAKT and Oncologix Tech

Can any of the company-specific risk be diversified away by investing in both TransAKT and Oncologix Tech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TransAKT and Oncologix Tech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between TransAKT and Oncologix Tech, you can compare the effects of market volatilities on TransAKT and Oncologix Tech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TransAKT with a short position of Oncologix Tech. Check out your portfolio center. Please also check ongoing floating volatility patterns of TransAKT and Oncologix Tech.

Diversification Opportunities for TransAKT and Oncologix Tech

0.0

Correlation Coefficient

TransAKT  Oncologix Tech

Pay attention - limited upside

The 3 months correlation between TransAKT and Oncologix is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding TransAKT and Oncologix Tech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncologix Tech and TransAKT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TransAKT are associated (or correlated) with Oncologix Tech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncologix Tech has no effect on the direction of TransAKT i.e., TransAKT and Oncologix Tech go up and down completely randomly.

Pair Corralation between TransAKT and Oncologix Tech

If you would invest  1.01  in TransAKT on September 3, 2024 and sell it today you would earn a total of  1.76  from holding TransAKT or generate 174.26% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

TransAKT  vs.  Oncologix Tech

TransAKT

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in TransAKT are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak forward-looking signals, TransAKT exhibited solid returns over the last few months and may actually be approaching a breakup point.

Oncologix Tech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncologix Tech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, Oncologix Tech is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with TransAKT and Oncologix Tech

The main advantage of trading using opposite TransAKT and Oncologix Tech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TransAKT position performs unexpectedly, Oncologix Tech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncologix Tech will offset losses from the drop in Oncologix Tech's long position.

The idea behind TransAKT and Oncologix Tech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.